Preoperative therapy in invasive breast cancer: reviewing the state of the science and exploring new research directions.

InMarch2007,theNationalCancerInstitute(NCI)sponsoredaState oftheScienceConferenceonPreoperativeTherapyinInvasiveBreast Cancer. The major goals of the conference were to review current clinical standards and to identify opportunities for future research. The conference did not seek to develop a consensus statement or a clinical guideline, but it did attempt to characterize appropriate clinical care. Importantly, an additional conference objective was to explore how research in the preoperative setting could be used to accelerate progress in the development of new and more effective treatments for individuals with breast cancer. In patients with operable breast cancer, randomized trials have demonstratedthatpreoperativeandpostoperativechemotherapy(us

[1]  D. Wickerham,et al.  Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  D. Berry,et al.  Research issues affecting preoperative systemic therapy for operable breast cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  S. Paik,et al.  Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  Barbara L. Smith,et al.  Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  D. Wickerham,et al.  The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  Neoadjuvant Trastuzumab Induces Apoptosis in Primary Breast Cancers , 2005 .

[7]  D. Mankoff,et al.  Locally advanced and inflammatory breast cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  Anna L. Brown,et al.  Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  E. Winer,et al.  Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.